Zhejiang Ausun Pharmaceutical Co., Ltd. (SHA:603229)
China · Delayed Price · Currency is CNY 10.16
-0.16 (-1.55%)
May 12, 2026, 3:00 PM CST
SHA:603229 Market Cap
SHA:603229 has a market cap or net worth of 8.55 billion as of May 12, 2026. Its market cap has increased by 37.82% in one year.
Market Cap
8.55B
Enterprise Value
7.88B
Revenue
794.80M
Ranking
n/a
PE Ratio
76.86
Stock Price
10.16
Market Cap Chart
Since May 9, 2017, SHA:603229's market cap has increased from 1.80B to 8.55B, an increase of 374.89%. That is a compound annual growth rate of 18.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 8.55B | 4.03% |
| Dec 31, 2025 | 8.22B | -0.94% |
| Dec 31, 2024 | 8.29B | 5.87% |
| Dec 29, 2023 | 7.83B | -18.09% |
| Dec 30, 2022 | 9.56B | -8.49% |
| Dec 31, 2021 | 10.45B | 19.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| May 9, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Youcare Pharmaceutical Group | 9.56B |
| Daan Gene | 9.32B |
| Aurisco Pharmaceutical | 9.23B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 8.94B |
| Sino Biological,Inc. | 8.78B |
| GemPharmatech | 8.40B |
| Bio-Thera Solutions | 8.30B |
| Nanjing Vazyme Biotech | 8.10B |